# FDA Inspection 1316082 - Aurobindo Pharma USA Inc - June 04, 2026

Source: https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/a13953a3-edc8-48d1-8c73-d267408050dd
Source feed: FDA_Inspections

> FDA Inspection 1316082 for Aurobindo Pharma USA Inc on June 04, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1316082
- Company Name: Aurobindo Pharma USA Inc
- Inspection Date: 2026-06-04
- Product Type: Human Drugs
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1238442 - 2024-05-15](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/653906f9-7952-4bff-9baa-c6b093dcc401)
- [FDA Inspection 908515 - 2014-12-12](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/f5f64249-fa72-42e3-b88d-44a5db92235c)
- [FDA Inspection 908515 - 2014-12-12](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/8aafb05c-4cf0-4b3b-9b91-e66abfff7110)
- [FDA Inspection 783745 - 2012-05-30](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/2fe29140-07b2-439a-8b7e-630234c4b31e)
- [FDA Inspection 736360 - 2011-07-29](https://www.keypedia.com/records/fda_inspections/aurobindo-pharma-usa-inc/bacfcc10-9940-4b19-9084-4bb60639c9f3)

Company: https://www.keypedia.com/companies/aurobindo-pharma-usa-inc/a8dbf5ca-1af1-432a-85b6-5a0c7499eaa5

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248